Aspira Women's Health Files S-1/A Update

TL;DR

Aspira Women's Health (AWH) filed an S-1/A on 2/11/25. Check financials for Q3 2024.

AI Summary

Aspira Women's Health Inc. filed an S-1/A on February 11, 2025, to update its registration statement. The company, formerly known as Vermillion, Inc., is in the in vitro & in vivo diagnostic substances industry and is based in Austin, TX. The filing includes financial data for periods ending September 30, 2024, and December 31, 2023, and 2022.

Why It Matters

This S-1/A filing provides updated information for investors and the market regarding Aspira Women's Health's financial status and corporate actions.

Risk Assessment

Risk Level: medium — S-1/A filings often indicate potential stock offerings or significant corporate changes, which carry inherent investment risks.

Key Numbers

• 2024-09-30 — Financial Reporting Period End (Latest reported quarter)
• 2023-12-31 — Financial Reporting Period End (Previous fiscal year end)
• 2022-12-31 — Financial Reporting Period End (Prior fiscal year end)

Key Players & Entities

• Aspira Women's Health Inc. (company) — Filer
• 0000926617 (company) — Central Index Key
• VERMILLION, INC. (company) — Former Company Name
• CIPHERGEN BIOSYSTEMS INC (company) — Former Company Name
• ABIOTIC SYSTEMS (company) — Former Company Name
• 20250211 (date) — Filing Date
• 2024-09-30 (date) — Financial Period End
• 2023-12-31 (date) — Financial Period End
• 2022-12-31 (date) — Financial Period End

FAQ

From the Filing

0001493152-25-005769.txt : 20250211 0001493152-25-005769.hdr.sgml : 20250211 20250211061307 ACCESSION NUMBER: 0001493152-25-005769 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 88 FILED AS OF DATE: 20250211 DATE AS OF CHANGE: 20250211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-284182 FILM NUMBER: 25607582 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 S-1/A 1 forms-1a.htm true 0000926617 S-1/A P3Y http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense http://fasb.org/us-gaap/2024#GeneralAndAdministrativeExpense 2024-12-31 2037-12-31 2024-12-31 2043-12-31 P1Y 0000926617 2024-01-01 2024-09-30 0000926617 dei:BusinessContactMember 2024-01-01 2024-09-30 0000926617 2023-12-31 0000926617 2022-12-31 0000926617 2024-09-30 0000926617 2023-01-01 2023-12-31 0000926617 2022-01-01 2022-12-31 0000926617 us-gaap:ProductMember 2023-01-01 2023-12-31 0000926617 us-gaap:ProductMember 2022-01-01 2022-12-31 0000926617 AWH:GeneticsMember 2023-01-01 2023-12-31 0000926617 AWH:GeneticsMember 2022-01-01 2022-12-31 0000926617 2024-07-01 2024-09-30 0000926617 2023-07-01 2023-09-30 0000926617 2023-01-01 2023-09-30 0000926617 us-gaap:ProductMember 2024-07-01 2024-09-30 0000926617 us-gaap:ProductMember 2023-07-01 2023-09-30 0000926617 us-gaap:ProductMember 2024-01-01 2024-09-30 0000926617 us-gaap:ProductMember 2023-01-01 2023-09-30 0000926617 AWH:GeneticsMember 2024-07-01 2024-09-30 0000926617 AWH:GeneticsMember 2023-07-01 2023-09-30 0000926617 AWH:GeneticsMember 2024-01-01 2024-09-30 0000926617 AWH:GeneticsMember 2023-01-01 2023-09-30 0000926617 us-gaap:CommonStockMember 2021-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000926617 us-gaap:RetainedEarningsMember 2021-12-31 0000926617 2021-12-31 0000926617 us-gaap:CommonStockMember 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2024-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000926617 us-gaap:RetainedEarningsMember 2024-03-31 0000926617 2024-03-31 0000926617 us-gaap:CommonStockMember 2024-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000926617 us-gaap:RetainedEarningsMember 2024-06-30 0000926617 2024-06-30 0000926617 us-gaap:CommonStockMember 2023-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000926617 us-gaap:RetainedEarningsMember 2023-03-31 0000926617 2023-03-31 0000926617 us-gaap:CommonStockMember 2023-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000926617 us-gaap:RetainedEarningsMember 2023-06-30 0000926617 2023-06-30 0000926617 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMembe